This document is a press release from Johnson & Johnson, detailing their second-quarter 2025 financial results and updated full-year outlook. It highlights the company's strong sales growth across both MedTech and Innovative Medicine segments, with specific figures provided for reported and adjusted operational sales and earnings per share. The release also emphasizes significant progress in their product pipeline, including new drug approvals and positive clinical trial data, which are expected to drive future growth. Finally, it outlines their revised financial guidance for the full year 2025, projecting increased sales and adjusted earnings, reflecting a positive operational performance.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
3ª PARTE | 17 DIC 2025 | EL PARTIDAZO DE COPE
01 Jan 1970
El Partidazo de COPE
13:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
12:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
10:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
13:00H | 20 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
12:00H | 20 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana